TY - JOUR
AU - Brendan Saloner
AU - Kenneth A. Feder
AU - Noa Krawczyk
A1 - 
AB - In years past, an adolescent patient presenting to primary care with symptoms of opioid use disorder (OUD) would have been a highly rare event in most communities. With OUD and fatal overdoses rising among adolescents and young adults (termed youth) over the past 15 years, this scenario has unfortunately become more common. Fatal drug overdoses increased 3.5-fold for youth aged 15 to 24 years from 1999 to 2014.1 Amidst this epidemic, relatively little is known about how primary care clinicians treat youth with OUD. Of particular interest is whether youth receive medication-assisted treatments (MATs), which have been shown to improve quality of life and reduce overdose risk.2
AD - Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland.
BT - JAMA pediatrics
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 8
CY - United States
DO - 10.1001/jamapediatrics.2017.1269
IS - 8
JF - JAMA pediatrics
LA - eng
M1 - Journal Article
N2 - In years past, an adolescent patient presenting to primary care with symptoms of opioid use disorder (OUD) would have been a highly rare event in most communities. With OUD and fatal overdoses rising among adolescents and young adults (termed youth) over the past 15 years, this scenario has unfortunately become more common. Fatal drug overdoses increased 3.5-fold for youth aged 15 to 24 years from 1999 to 2014.1 Amidst this epidemic, relatively little is known about how primary care clinicians treat youth with OUD. Of particular interest is whether youth receive medication-assisted treatments (MATs), which have been shown to improve quality of life and reduce overdose risk.2
PP - United States
PY - 2017
SN - 2168-6211; 2168-6203
SP - 729
EP - 731
EP - 
T1 - Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder
T2 - JAMA pediatrics
TI - Closing the Medication-Assisted Treatment Gap for Youth With Opioid Use Disorder
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 28628699
U3 - 10.1001/jamapediatrics.2017.1269
VL - 171
VO - 2168-6211; 2168-6203
Y1 - 2017
Y2 - Aug 1
ER -